Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 20 de 42
Filter
1.
Georgian Med News ; (338): 63-68, 2023 May.
Article in English | MEDLINE | ID: mdl-37419473

ABSTRACT

The Aloe vera plant is a cactus-like plant in the Liliacea family that has been known and utilized for its medical benefits. It has been attempted to be used as a remineralizing agent and shows an antibacterial effect. Aim of the study - assessment of the remineralizing effect of solution of saturated Aloe vera gel compared to distal water by microhardness Vickers test and Densometric X-Ray Analysis and effect of Aloe vera gel against Enterococcus faecalis. 10 extracted permanent molars were used in this in vitro study. each tooth enrolls in Teflon tape and only the enamel of the occlusal surface was exposed to a demineralizing solution (acid etch) for 45 seconds in-vitro and randomly assigned to two groups: Group 1 was treated with distal water; group 2 was treated with Aloe vera gel. All groups except the control baseline group were treated with their respective remineralizing solution for 10 days. Vicker's Microhardness Number (VHN) and Densometric X-Ray Analysis were carried out at baseline, post-demineralization and later post 10 days of remineralization. The antibacterial effect of Aloe vera gel was assessed by the disc diffusion method. The filter paper was immersed in 20µl of different concentrations of Aloe vera gel extract as fresh Aloe vera (100 %) and (50 % and 25 %) diluted with de-ionized water after that the disc was distributed in a plate containing the E. faecalis. Antibiotics disc of Augmentin (Amoxicillin and Clavulanic acid 30ug) were also poured in the same plate and incubated at 37°C for 24 hours and the zone of inhibition of antibiotic was measured for comparison with a zone of inhibition of filter paper saturated with Aloe vera gel. Densitometric X-Ray Analysis and Microhardness Number (VHN) evaluation showed improvement in the enamel density and the surface hardness after remineralization. The mean value in the group treated with Aloe vera solution was higher than the recorded mean value for the group treated with distal water. There was a significant difference between Aloe vera solution and distal water. Significant (p-value≤0.05) after 10 days. The antibacterial effect showed that E. faecalis was resistant to Aloe vera gel in different concentrations compared with Augmentin (Amoxicillin and Clavulanic acid 30ug). Aloe vera gel could be used for caries prevention in terms of safety and efficiency. While E. faecalis show resistance activity against Aloe vera gel.


Subject(s)
Amoxicillin-Potassium Clavulanate Combination , Enterococcus faecalis , Amoxicillin-Potassium Clavulanate Combination/pharmacology , Anti-Bacterial Agents/pharmacology , Anti-Bacterial Agents/therapeutic use , Amoxicillin/pharmacology
2.
Georgian Med News ; (339): 57-61, 2023 Jun.
Article in English | MEDLINE | ID: mdl-37522775

ABSTRACT

Pain is a common experience that can range from mild annoyance to debilitating agony. As such, finding effective ways to relieve pain is a crucial aspect of healthcare. Aspirin, a nonsteroidal anti-inflammatory drug (NSAID), is a commonly used analgesic that works by inhibiting the production of prostaglandins, which are responsible for causing pain. However, the effectiveness of aspirin can be influenced by various factors, including the form in which it is administered. The current study aimed to compare the effects of aspirin's ordinary particles and nanoparticles as an analgesic utilizing the hot plate method in topical formulations (gel, ointment, cream). The study employed 120 albino mice, all males, divided into six groups. In the three groups, aspirin was topically applied using various formulations (gel, cream, and ointment, respectively) and concentrations (0.25, 0.5, and 1%). The same composition and concentration of aspirin nanoparticles were administered to the other three groups. The reaction time was assessed after aspirin was topically applied at 2-, 10-, 20-, 30-, 40-, 50- and 60-minute intervals. Extended delay durations in comparison to control values were used to express the ant-nociceptive effects of aspirin. The results of the study showed that aspirin nanoparticles produced the best analgesic impact, followed by the cream and then the ointment, according to the data. This suggests that the form in which aspirin is administered can significantly influence its effectiveness as an analgesic. The use of nanoparticles may increase the bioavailability of aspirin, allowing it to be more efficiently absorbed by the body and produce a more significant analgesic effect. Overall, the study's findings suggest that aspirin nanoparticles may be a more effective form of aspirin for pain relief than ordinary particles. Further research is needed to explore the potential benefits and drawbacks of this form of aspirin and determine its efficacy in human subjects. Nevertheless, the current study provides valuable insights into the factors that can influence the effectiveness of aspirin as an analgesic and may inform future developments in pain management.


Subject(s)
Aspirin , Nanoparticles , Mice , Male , Animals , Humans , Aspirin/pharmacology , Aspirin/therapeutic use , Nociception , Ointments , Pain/drug therapy , Nanoparticles/therapeutic use
3.
Craniomaxillofac Trauma Reconstr ; 15(1): 21-27, 2022 Mar.
Article in English | MEDLINE | ID: mdl-35265273

ABSTRACT

Study Design: Retrospective Cohort Study. Objective: Yearly, bicycle and scooter accidents in the Netherlands amount to 90 thousand emergency department visits. Maxillofacial injuries are common after cycling or scooter accidents. To prevent these injuries, helmet use might be beneficial. However, the effect of helmet use on maxillofacial injuries remains unclear. The aim of this retrospective study is to assess the effect of helmet use on maxillofacial injuries in patients who had a bicycle or scooter accident. Methods: We collected data from the emergency department of the Erasmus Medical Center in the period from October 2017 to October 2019. Patients that were involved in a bicycle or scooter accident and subsequently received a CT scan of the head were included. We compared the incidence of maxillofacial injuries in helmeted cyclists and scooter users to non-helmeted users. Descriptive and analytic statistics were computed. Level of statistical significance was set at p < 0.05. Results: Helmet use among scooter users was associated with a significant reduction in maxillofacial fractures (p < 0.001) and soft tissue injuries (p < 0.001). Helmet use among cyclists was not associated with a reduction in maxillofacial fractures (p = 0.17) or soft tissue injuries (p = 0.30). Helmet use was not associated with a reduction in soft tissue injuries of the lower face in both cyclists (p = 0.47) and scooter users (p = 0.24). Conclusions: Helmet use should be considered among cyclists and scooter users to prevent maxillofacial injuries. Especially unhelmeted scooter users might benefit from helmet use as this is associated with a lower incidence of maxillofacial injuries.

4.
J Orofac Orthop ; 79(2): 96-108, 2018 Mar.
Article in English | MEDLINE | ID: mdl-29464289

ABSTRACT

AIM: To investigate the long-term (≥15 years) benefit of orthodontic Class II treatment (Tx) on oral health (OH). SUBJECTS AND METHODS: All patients (Department of Orthodontics, University of Giessen, Giessen, Germany) who underwent Class II correction (Herbst-multibracket Tx, end of active Tx ≥ 15 years ago) and agreed to participate in a recall (clinical examination, interview, impressions, and photographs) were included. Records after active Tx were used to assess the long-term OH effects. Data were compared to corresponding population-representative age-cohorts as well as to untreated Class I controls without orthodontic Tx need during adolescence. RESULTS: Of 152 treated Class II patients, 75 could be located and agreed to participate at 33.7 ± 3.0 years of age (pre-Tx age: 14.0 ± 2.7 years). The majority (70.8%) were fully satisfied with their teeth and with their masticatory system. The Decayed, Missing, Filled Teeth Index (DMFT) was 7.1 ± 4.8 and, thus, almost identical to that of the untreated Class I controls (7.9 ± 3.6). In contrast, the DMFT in the population-representative age-cohort was 56% higher. The determined mean Community Periodontal Index (CPI) maximum score (1.6 ± 0.6) was also comparable to the untreated Class I controls (1.7 ± 0.9) but in the corresponding population-representative age-cohort it was 19-44% higher. The extent of lower incisor gingival recessions did not differ significantly between the treated Class II participants and the untreated Class I controls (0.1 ± 0.2 vs. 0.0 ± 0.1 mm). CONCLUSION: Patients with orthodontically treated severe Class II malocclusions had a lower risk for oral health impairment than the general population. The risk corresponded to that of untreated Class I controls (without orthodontic Tx need during adolescence).


Subject(s)
Malocclusion, Angle Class II/therapy , Oral Health , Orthodontics, Corrective , Adult , Cohort Studies , DMF Index , Dental Caries/etiology , Female , Follow-Up Studies , Humans , Male , Patient Satisfaction , Periodontal Diseases/etiology
5.
East Mediterr Health J ; 15(1): 136-42, 2009.
Article in English | MEDLINE | ID: mdl-19469436

ABSTRACT

The seroprevalence of hepatitis E virus infection (HEV) in children and young adults was determined in a community-based survey in an area of northern Islamic Republic of Iran. Serum samples were taken from 1080 randomly selected apparently healthy 2-25-year-olds from urban and rural regions of Sari district. Anti-HEV IgG antibodies were detected in 25 individuals (2.3%). Seroprevalence increased significantly with age from 3/255 (1.2%) in children < 10 years to 8/110 (7.3%) in those aged 20-25 years. No differences in HEV status were noted between the sexes. Earlier age at exposure to infection and a higher infection rate were found in people residing in rural areas than in urban areas.


Subject(s)
Endemic Diseases/statistics & numerical data , Hepatitis E virus , Hepatitis E/epidemiology , Adolescent , Adult , Age Distribution , Antibodies, Viral/blood , Chi-Square Distribution , Child , Child, Preschool , Cross-Sectional Studies , Female , Hepatitis E/blood , Hepatitis E/immunology , Hepatitis E virus/immunology , Humans , Immunoglobulin G/blood , Iran/epidemiology , Male , Multivariate Analysis , Population Surveillance , Risk Factors , Rural Health/statistics & numerical data , Seroepidemiologic Studies , Sex Distribution , Socioeconomic Factors , Urban Health/statistics & numerical data , Young Adult
6.
Eur J Clin Microbiol Infect Dis ; 28(7): 845-7, 2009 Jul.
Article in English | MEDLINE | ID: mdl-19229565

ABSTRACT

This study was conducted to assess the roles of maternal measles-rubella (MR) vaccination before pregnancy on the persistence of passive immunity against MR in their infant before measles-mumps-rubella (MMR) immunization and the effects on the immunogenicity of MMR vaccine. Before and 4-8 weeks after MMR immunization of all healthy 12-month-old infants, sera samples were prepared. According to their mother's history of MR vaccination, infants were divided into two groups. Anti-MR antibodies were measured by the quantitative enzyme-linked immunosorbent assay (ELISA) method. The difference in seroconversion rates and the mean concentration of antibodies (MCA) between the two groups of infants were analyzed by descriptive statistical methods. In total, 7 and 12 sera, all from infants born from MR-vaccinated mothers, were positive against measles and rubella, respectively. The seroconversion rates were 90.5 and 53% in seronegative infants against measles and rubella, respectively, without statistically significant differences between the two groups of infants. However, the MCA differences were significant; measles P = 0.000, rubella P = 0.019. The MR vaccination of mothers may cause the prolongation of passive immunity in their infants, and may influence the immunogenicity of MMR vaccination. This finding should be considered for the optimal scheduling of the first dose of MMR vaccine. Also, the results showed that the immunogenicity of the rubella component of the MMR vaccine was lower than that reported.


Subject(s)
Measles-Mumps-Rubella Vaccine/immunology , Measles/prevention & control , Mumps/prevention & control , Rubella/prevention & control , Adult , Antibodies, Viral/blood , Enzyme-Linked Immunosorbent Assay , Female , Humans , Immunity, Maternally-Acquired , Immunization Schedule , Infant , Male , Measles/immunology , Mumps/immunology , Rubella/immunology , Young Adult
7.
East Mediterr Health J ; 15(4): 785-91, 2009.
Article in English | MEDLINE | ID: mdl-20187529

ABSTRACT

Treatment of chronic hepatitis C virus (HCV) infection in transfusion-dependent beta-thalassaemia major patients is complicated by existing hepatic siderosis and the fear of ribavirin-associated haemolysis. We evaluated the efficacy and side-effects of combination interferon-alpha (INF) and ribavirin therapy for HCV-infected thalassaemia patients. A total of 17 patients were enrolled (10 nonresponders to INF monotherapy, 7 naive to treatment, mean age 23.1 years) and they received 12 months of combination therapy. The sustained virological response rate 6 months after treatment was 58.8%. Blood transfusion requirements during treatment temporarily increased by 36.6%. Combination therapy was tolerated by, and may be useful for, HCV-infected thalassaemia major patients.


Subject(s)
Antiviral Agents/therapeutic use , Hepatitis C, Chronic/complications , Hepatitis C, Chronic/drug therapy , Interferon Type I/therapeutic use , Ribavirin/therapeutic use , beta-Thalassemia/complications , Adolescent , Adult , Alanine Transaminase/blood , Biopsy , Blood Transfusion/statistics & numerical data , Drug Monitoring , Drug Therapy, Combination , Female , Ferritins/blood , Hemosiderosis/etiology , Hemosiderosis/prevention & control , Hepacivirus/drug effects , Hepacivirus/genetics , Hepatitis C, Chronic/metabolism , Hepatitis C, Chronic/virology , Humans , Iran , Male , RNA, Viral/blood , RNA, Viral/drug effects , Recombinant Proteins , Transfusion Reaction , Treatment Outcome , beta-Thalassemia/blood , beta-Thalassemia/therapy
8.
(East. Mediterr. health j).
in English | WHO IRIS | ID: who-117699

ABSTRACT

Treatment of chronic hepatitis C virus [HCV] infection in transfusion-dependent betathalassaemia major patients is complicated by existing hepatic siderosis and the fear of ribavirinassociated haemolysis. We evaluated the efficacy and side-effects of combination interferon-alpha [INF] and ribavirin therapy for HCV-infected thalassaemia patients. A total of 17 patients were enrolled [10 nonresponders to INF monotherapy, 7 naive to treatment, mean age 23.1 years] and they received 12 months of combination therapy. The sustained virological response rate 6 months after treatment was 58.8%. Blood transfusion requirements during treatment temporarily increased by 36.6%. Combination therapy was tolerated by, and may be useful for, HCV-infected thalassaemia major patients


Subject(s)
Drug Therapy, Combination , Interferons , Ribavirin , beta-Thalassemia , Blood Transfusion , Treatment Outcome , Hepatitis C, Chronic
9.
(East. Mediterr. health j).
in English | WHO IRIS | ID: who-117618

ABSTRACT

The seroprevalence of hepatitis E virus infection [HEV] in children and young adults was determined in a community-based survey in an area of northern Islamic Republic of Iran. Serum samples were taken from 1080 randomly selected apparently healthy 2-25-year-olds from urban and rural regions of Sari district. Anti-HEV IgG antibodies were detected in 25 individuals [2.3%]. Seroprevalence increased significantly with age from 3/255 [1.2%] in children < 10 years to 8/110 [7.3%] in those aged 20-25 years. No differences in HEV status were noted between the sexes. Earlier age at exposure to infection and a higher infection rate were found in people residing in rural areas than in urban areas


Subject(s)
Hepatitis E , Seroepidemiologic Studies , Health Surveys , Immunoglobulin G , Rural Population , Age Distribution , Cross-Sectional Studies , Prevalence
10.
East Mediterr Health J ; 14(3): 556-63, 2008.
Article in English | MEDLINE | ID: mdl-18720619

ABSTRACT

To determine the frequency and pattern of antibiotic susceptibility of uropathogens in urinary tract infection (UTI) from 3 university hospitals we carried out a retrospective review of urine culture and antibiotic sensitivity testing from symptomatic outpatients and inpatients during 2002-2003. Of 5600 samples, 703 (12.6%) were culture positive, 38.7% of which were from hospitalized patients. Escherichia coli was the leading cause of UTI in both groups of patients. The rates and roles of other pathogens, including Pseudomonas spp. (5.3%-10.4%), Enterobacter spp. (0%-5.7%), Staphylococcus spp.) 5.4%-26.4%), differed in each hospital. Differences in antibacterial susceptibility patterns were observed. Ampicillin (82%-100%) and co-trimoxazole (50%-90%) resistance were the most frequent. Methicillin resistance in Staphylococcus spp. ranged from 17% to 60%.


Subject(s)
Community-Acquired Infections/epidemiology , Community-Acquired Infections/microbiology , Cross Infection/epidemiology , Cross Infection/microbiology , Urinary Tract Infections/epidemiology , Urinary Tract Infections/microbiology , Adult , Chi-Square Distribution , Child , Community-Acquired Infections/drug therapy , Cross Infection/drug therapy , Drug Resistance, Bacterial , Enterobacteriaceae Infections/epidemiology , Escherichia coli Infections/epidemiology , Female , Hospitals, University , Humans , Infant, Newborn , Iran/epidemiology , Male , Microbial Sensitivity Tests , Population Surveillance , Pseudomonas Infections/epidemiology , Retrospective Studies , Risk Factors , Sex Distribution , Staphylococcal Infections/epidemiology , Urinalysis , Urinary Tract Infections/drug therapy
11.
Indian Pediatr ; 45(7): 590-2, 2008 Jul.
Article in English | MEDLINE | ID: mdl-18695281

ABSTRACT

We conducted this study to determine the contribution of respiratory viruses in 202 hospitalized children (1 mo-5 yr) with clinical evidence of acute lower respiratory tract illness (ALRI). Nasopharyngeal specimens were assayed for viruses detection by indirect immunoflourescent method. Viral agents were identified from 109 (54%) cases (9 cases had dual infection). The most commonly detected virus was parainfluenza virus 3 in 32 (15.8%) cases followed by respiratory syncytial virus 26 (12.9%) parainfluenza 1 and parainfluenza 2 each 13 (6.4%) influenza A 16 (7.4%), influenza B; 7(3.5%), and adenovirus 12 (5.9%). There were no demographic, clinical, radiologic or laboratory parameters except for recurrent wheeze (OR: 4.47; (95% CI: 1.98-10.73) and fever (OR: 3.27; (95% CI: 1.73-6.20), which could differentiate between patients with or without viral etiology.


Subject(s)
Lung/microbiology , Respiratory Tract Infections , Anti-Bacterial Agents/therapeutic use , Catchment Area, Health , Child, Preschool , Female , Hospitalization , Humans , Infant , Iran/epidemiology , Male , Nasopharynx/microbiology , Paramyxoviridae Infections/complications , Paramyxoviridae Infections/epidemiology , Paramyxoviridae Infections/rehabilitation , Respiratory Distress Syndrome/epidemiology , Respiratory Distress Syndrome/microbiology , Respiratory Distress Syndrome/rehabilitation , Respiratory Syncytial Virus Infections/complications , Respiratory Syncytial Virus Infections/epidemiology , Respiratory Syncytial Virus Infections/rehabilitation , Respiratory Tract Infections/epidemiology , Respiratory Tract Infections/microbiology , Respiratory Tract Infections/rehabilitation
12.
J Laryngol Otol ; 122(3): 307-9, 2008 Mar.
Article in English | MEDLINE | ID: mdl-17666126

ABSTRACT

OBJECTIVE: Preterm infants with respiratory distress are routinely treated by application of nasal mask continuous positive airway pressure. In preterm infants with cleft lip and palate, nasal mask attachment is not feasible due to air leakage through the cleft defect. Here, we describe a modified continuous positive airway pressure application method that overcomes this problem. DESIGN AND SUBJECTS: Observation study, university neonatal intensive care unit. The neonates (n = 4) were between 28 and 33 weeks' gestation and weighed 1160 to 1680 g at birth. Immediately after birth, infants with unilateral cleft lip and palate (n = 3) were respiratory stabilised by a Medijet generator using a nasal tube. To minimise the pressure cap, hydrocolloid bandages were adhered over the total cleft defect. Immediately after orthodontic passive palatal plates insertion (within 27 hours of life), the nasal tube was removed and continuous positive airway pressure was applied through a nasal mask covering the complete nose of the infant. RESULTS: The system proved suitable for patients with unilateral cleft lip and palate for whom the generated nasal mask continuous positive airway pressure remained constant between 5 to 7 cm of water but failed in the patient with bilateral cleft lip and palate. None of the patients had to be ventilated due to respiratory failure, and all survived to discharge. CONCLUSION: Preterm infants with unilateral, but not bilateral cleft lip and palate, can be successfully stabilised using the described nasal mask continuous positive airway pressure system, thereby avoiding primary intubation and its associated risk of complications.


Subject(s)
Cleft Lip/complications , Cleft Palate/complications , Continuous Positive Airway Pressure/methods , Infant, Premature, Diseases/therapy , Respiratory Distress Syndrome, Newborn/therapy , Female , Humans , Infant, Newborn , Infant, Premature , Male , Treatment Outcome
13.
(East. Mediterr. health j).
in English | WHO IRIS | ID: who-117466

ABSTRACT

To determine the frequency and pattern of antibiotic susceptibility of uropathogens in urinary tract infection [UTI] from 3 university hospitals we carried out a retrospective review of urine culture and antibiotic sensitivity testing from symptomatic outpatients and inpatients during 2002-2003. Of 5600 samples, 703 [12.6%] were culture positive, 38.7% of which were from hospitalized patients. Escherichia coli was the leading cause of UTI in both groups of patients. The rates and roles of other pathogens, including Pseudomonas spp. [5.3%-10.4%], Enterobacter spp. [0%-5.7%], Staphylococcus spp.] 5.4%-26.4%], differed in each hospital. Differences in antibacterial susceptibility patterns were observed. Ampicillin [82%-100%] and co-trimoxazole [50%-90%] resistance were the most frequent. Methicillin resistance in Staphylococcus spp. ranged from 17% to 60%


Subject(s)
Urinary Tract Infections , Culture Media , Urine , Escherichia coli , Pseudomonas , Enterobacter , Ampicillin Resistance , Trimethoprim Resistance , Methicillin Resistance , Hospitals , Microbial Sensitivity Tests
14.
Trop Doct ; 37(1): 30-2, 2007 Jan.
Article in English | MEDLINE | ID: mdl-17326884

ABSTRACT

To determine the incidence and characteristics of measles, cases reported to the Health Center for Diseases Control 2000-2002 were reviewed. Demographics data, vaccination status and its relation to occurrence the disease were analysed. A total of 729 cases (270 women,162, 269, 298, over the 3 years) were reported. The annual incidence rates over the 3 years were 7.1, 11.9 and 12.7 for each 10(5) population. In full vaccinated subjects, 46.5% of the cases occurred and 39.9% of the cases had not been vaccinated. Because of the high incidence rate of measles both in vaccinated and unvaccinated individuals, paying more attention to proper shipping and storing of vaccine, and even catch-up immunization for increasing herd immunity are recommended.


Subject(s)
Health Services Accessibility , Immunization Programs/statistics & numerical data , Measles Vaccine/supply & distribution , Measles/epidemiology , Measles/prevention & control , Adolescent , Adult , Child , Child, Preschool , Demography , Female , Humans , Incidence , Infant , Infant, Newborn , Iran/epidemiology , Male , Measles/etiology , Preventive Health Services , State Government
15.
Indian Pediatr ; 44(12): 916-8, 2007 Dec.
Article in English | MEDLINE | ID: mdl-18175845

ABSTRACT

This study was designed to evaluate seroprevalence rates of antibodies to pertussis in mothers and their infants, and the immunogenicity of pertussis vaccine in the presence or absence of pertussis antibodies in infants. Blood samples were collected from 110 mother-infants pairs before the first dose of pertussis vaccination and from 69 infants 4-8 weeks after administration of the third dose of DTwP vaccine. Pertussis antibodies were >25 U/mL in 88(78.9%) mothers and 50(45.3%) infants with a mean titer of 67(SD 48.1) and 33.5 (34.7) U/mL, respectively. After administration of three doses of DTwP vaccine, 53(76.8%) infants were seroconverted (MCA titer 87.4 (51.3)U/mL. Immunologic response to vaccination was similar between the two groups of infants; 30/37 (81.1%) of seronegative infants and 23/32 (71.9%) of seropositive infants at pre-vaccination, showed seroconversion after the vaccination (P = 0.36). The results of this study demonstrated that most of the studied mothers were serologically immune to pertussis, and this immunity was transferred to their infants. Pre-vaccination antibody did not affect infants immune response to vaccination.


Subject(s)
Antibodies, Bacterial/blood , Bordetella pertussis/immunology , Diphtheria-Tetanus-Pertussis Vaccine/immunology , Vaccination , Whooping Cough/prevention & control , Adult , Diphtheria-Tetanus-Pertussis Vaccine/administration & dosage , Female , Humans , Immunoglobulin G , Infant , Pilot Projects , Seroepidemiologic Studies , Whooping Cough/blood , Whooping Cough/immunology
16.
East Mediterr Health J ; 12(5): 573-81, 2006 Sep.
Article in English | MEDLINE | ID: mdl-17333796

ABSTRACT

We evaluated the seroprevalence of measles antibody and response to measles reimmunization in 590 previously vaccinated adolescents and young adults; 263 were seronegative. To differentiate between primary and secondary vaccine failure, anti-measles IgM and IgG titres were assessed again 2-4 weeks after revaccination in 144 (105 seronegative, 39 seropositive) individuals: 75 seronegative participants responded to revaccination anamnestically (P < 0.001) and developed immunity, 11 also showed IgM response (probably primary vaccine failure); 38 seropositive participants remained seroprotected without significant increase in antibody titre (P = 0.577). Primary vaccine failure was 4.7%; secondary vaccine failure was 27.1%. After revaccination, 87.3% were seroprotected.


Subject(s)
Immunization, Secondary/methods , Mass Vaccination/methods , Measles Vaccine/immunology , Measles/epidemiology , Measles/prevention & control , Adolescent , Adult , Aftercare , Antibodies, Viral/blood , Enzyme-Linked Immunosorbent Assay , Female , Health Services Needs and Demand , Humans , Immunization Schedule , Immunoglobulin G/blood , Immunoglobulin M/blood , Iran/epidemiology , Male , Mass Screening/methods , Measles/blood , Measles/immunology , Measles virus/immunology , Population Surveillance , Seroepidemiologic Studies , Treatment Failure
17.
(East. Mediterr. health j).
in English | WHO IRIS | ID: who-117121

ABSTRACT

We evaluated the seroprevalence of measles antibody and response to measles re-immunization in 590 previously vaccinated adolescents and young adults; 263 were seronegative. To differentiate between primary and secondary vaccine failure, anti- measles IgM and IgG titres were assessed again 2- 4 weeks after revaccination in 144 [105 seronegative, 39 seropositive] individuals: 75 seronegative participants responded to revaccination anamnestically [P < 0.001] and developed immunity 11 also showed IgM response [probably primary vaccine failure immunity]; 38 seropositive participants, remained seroprotected without significant increase in antibody titre [P = 0.577]. Primary vaccine failure was 4.7%; secondary vaccine failure was 27.1%. After revaccination, 87.3% were seroprotected


Subject(s)
Measles , Measles Vaccine , Monitoring, Immunologic , Serologic Tests
19.
East Mediterr Health J ; 11(1-2): 28-35, 2005.
Article in English | MEDLINE | ID: mdl-16532668

ABSTRACT

We conducted a retrospective review of all cases of Kawasaki disease admitted to the major referral centres in Sari, East Mazandaran from 1 November 1997 to 30 October 2002. Of 29 probable cases, 25 were confirmed, giving an average annual incidence rate of 7.3 per 100 000 in children 0-5 years. The mean age of all cases was 38 months (range: 3.5-80 months). There was a male predominance. The mean time between the onset of illness and diagnosis was 8.2 +/- 3.1 days. Five of the 25 patients had cardiovascular abnormalities before treatment. All patients were treated with intravenous immunoglobulin and 22 (88%) responded to a single dose of treatment and high doses of acetylsalicylic acid; 2 patients needed a second dose of IVIG, and 1 patient required a third. Complete recovery was noted in all patients except for 1, who is under follow-up and treatment.


Subject(s)
Mucocutaneous Lymph Node Syndrome , Urban Health/statistics & numerical data , Age Distribution , Anti-Inflammatory Agents, Non-Steroidal/therapeutic use , Aspirin/therapeutic use , Child , Child, Preschool , Echocardiography , Female , Humans , Immunoglobulins, Intravenous/therapeutic use , Immunologic Factors/therapeutic use , Incidence , Infant , Infant, Newborn , Iran/epidemiology , Male , Mucocutaneous Lymph Node Syndrome/diagnosis , Mucocutaneous Lymph Node Syndrome/drug therapy , Mucocutaneous Lymph Node Syndrome/epidemiology , Patient Admission/statistics & numerical data , Population Surveillance , Referral and Consultation/statistics & numerical data , Retrospective Studies , Seasons , Sex Distribution , Time Factors , Treatment Outcome
20.
East Mediterr Health J ; 11(1-2): 73-8, 2005.
Article in English | MEDLINE | ID: mdl-16532674

ABSTRACT

We selected 40S children aged 1-10 years with Giardia lamblia infection but without abdominal orgastrointestinal complaints for the previous month. For 5 days, 204 received metronidazole 15 mg/kg/day and 201 received B-complex syrup. Stool samples were examined 2-3 weeks and 3 months after treatment and results were tested with chi-squared. Weight and height 6 months after treatment were compared with primary weight and height by Z-score and Student t-test. Metronidazole efficacy at 2-3 weeks was 85.3%. Three months after treatment, 60 were reinfected (34.5%) and 71 had spontaneously cleared (35.3%). Because of high reinfection, spontaneous clearing and treatment failure rates, and the lack of effect on nutritional status or growth, we do not recommend treatment for children with asymptomatic giardia infection.


Subject(s)
Antiprotozoal Agents/therapeutic use , Endemic Diseases/prevention & control , Giardiasis/drug therapy , Metronidazole/therapeutic use , Age Distribution , Body Height , Body Weight , Chi-Square Distribution , Child , Child Nutrition Disorders/parasitology , Child, Preschool , Developing Countries , Endemic Diseases/statistics & numerical data , Feces/parasitology , Female , Giardiasis/diagnosis , Giardiasis/epidemiology , Giardiasis/parasitology , Growth Disorders/parasitology , Humans , Infant , Iran/epidemiology , Male , Population Surveillance , Prevalence , Recurrence , Sex Distribution , Socioeconomic Factors , Treatment Failure , Vitamin B Complex/therapeutic use
SELECTION OF CITATIONS
SEARCH DETAIL
...